Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma

Biochemical and Biophysical Research Communications

Volumn 452, Issue 3, 2014, Pages 567-574

  Zhu, Pengfei ^a   Lv, Jun ^b   Yang, Ziwei ^a   Guo, Limei ^a   Zhang, Ling ^c   Li, Meng ^a   Han, Wenling ^a   Chen, Xiangmei ^a   Zhuang, Hui ^a   Lu, Fengmin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Henan Cancer Hospital   (China)

Author keywords

EMT; GSK 3 ; Hepatocellular carcinoma; Protocadherin 9; Tumor suppressor gene

Indexed keywords

CADHERIN; GLYCOGEN SYNTHASE KINASE 3BETA; PROTOCADHERIN 9; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PCDH9 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; CELL MIGRATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PORTAL VEIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PORTAL VEIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84907533336     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.08.101     Document Type: Article

References (30)

1. M.C. Kew Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma Pathol. Biol. (Paris) 58 2010 273 277
2. D. Samuel, M. Colombo, H. El-Serag, R. Sobesky, and N. Heaton Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma Liver Transpl. 17 2011 S6 S13
3. A.X. Zhu, D.G. Duda, D.V. Sahani, and R.K. Jain HCC and angiogenesis: possible targets and future directions Nat. Rev. Clin. Oncol. 8 2011 292 301
4. A.F. Chambers, A.C. Groom, and I.C. MacDonald Metastasis: dissemination and growth of cancer cells in metastatic sites Nat. Rev. Cancer 2 2002 563 572
5. M. Frank, and R. Kemler Protocadherins Curr. Opin. Cell Biol. 14 2002 557 562
6. S.Y. Kim, S. Yasuda, H. Tanaka, K. Yamagata, and H. Kim Non-clustered protocadherin Cell Adh. Migr. 5 2011 97 105
7. K. Sano, H. Tanihara, R.L. Heimark, S. Obata, M. Davidson, T. St John, S. Taketani, and S. Suzuki Protocadherins: a large family of cadherin-related molecules in central nervous system EMBO J. 12 1993 2249 2256
8. T. Yagi, and M. Takeichi Cadherin superfamily genes: functions, genomic organization, and neurologic diversity Genes Dev. 14 2000 1169 1180
9. H. Morishita, and T. Yagi Protocadherin family: diversity, structure, and function Curr. Opin. Cell Biol. 19 2007 584 592
10. J.S. Yu, S. Koujak, S. Nagase, C.M. Li, T. Su, X. Wang, M. Keniry, L. Memeo, A. Rojtman, M. Mansukhani, H. Hibshoosh, B. Tycko, and R. Parsons PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer Oncogene 27 2008 4657 4665
11. C. Wang, G. Yu, J. Liu, J. Wang, Y. Zhang, X. Zhang, Z. Zhou, and Z. Huang Downregulation of PCDH9 predicts prognosis for patients with glioma J. Clin. Neurosci. 19 2012 541 545
12. X. Zhong, Y. Zhu, J. Mao, J. Zhang, and S. Zheng Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer J. Cancer Res. Clin. Oncol. 139 2013 485 490
13. X. Hu, X. Sui, L. Li, X. Huang, R. Rong, X. Su, Q. Shi, L. Mo, X. Shu, Y. Kuang, Q. Tao, and C. He Protocadherin 17 acts as a tumor suppressor inducing tumor cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers J. Pathol. 229 2013 62 73
14. I. Imoto, H. Izumi, S. Yokoi, H. Hosoda, T. Shibata, F. Hosoda, M. Ohki, S. Hirohashi, and J. Inazawa Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers Cancer Res. 66 2006 4617 4626
15. M. de Tayrac, A. Etcheverry, M. Aubry, S. Saikali, A. Hamlat, V. Quillien, A. Le Treut, M.D. Galibert, and J. Mosser Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression Genes Chromosom. Cancer 48 2009 55 68
16. S. Jiang, Z. Yang, W. Li, X. Li, Y. Wang, J. Zhang, C. Xu, P.J. Chen, J. Hou, M.A. McCrae, X. Chen, H. Zhuang, and F. Lu Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis PLoS One 7 2012 e40363
17. Y. Wang, J. Cheng, C. Xu, S. Liu, S. Jiang, Q. Xu, X. Chen, H. Zhuang, and F. Lu Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma Liver Int. 32 2012 420 428
18. S. Liu, P. Zhu, L. Zhang, S. Ding, S. Zheng, Y. Wang, and F. Lu Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis Cancer Biomark. 13 2013 345 349
19. J. Lv, P. Zhu, Z. Yang, M. Li, X. Zhang, J. Cheng, X. Chen, and F. Lu PCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/b-catenin signalling pathway in hepatocellular carcinoma J. Viral Hepat. 2014 10.1111/jvh.12265 (Epub ahead of print)
20. E. Batlle, E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, and D.H.A. Garcia The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nat. Cell Biol. 2 2000 84 89
21. B.P. Zhou, J. Deng, W. Xia, J. Xu, Y.M. Li, M. Gunduz, and M.C. Hung Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition Nat. Cell Biol. 6 2004 931 940
22. X. Zhang, H.J. Xu, Y. Murakami, R. Sachse, K. Yashima, S. Hirohashi, S.X. Hu, W.F. Benedict, and T. Sekiya Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma Cancer Res. 54 1994 4177 4182
23. D.J. Simpson, J. Magnay, J.E. Bicknell, A.L. Barkan, A.M. McNicol, R.N. Clayton, and W.E. Farrell Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas Cancer Res. 59 1999 1562 1566
24. C.M. Wong, J.M. Lee, T.C. Lau, S.T. Fan, and I.O. Ng Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma Clin. Cancer Res. 8 2002 2266 2272
25. B. Skawran, D. Steinemann, T. Becker, R. Buurman, J. Flik, B. Wiese, P. Flemming, H. Kreipe, B. Schlegelberger, and L. Wilkens Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma Mod. Pathol. 21 2008 1479 1489
26. J. Zavadil, J. Haley, R. Kalluri, S.K. Muthuswamy, and E. Thompson Epithelial-mesenchymal transition Cancer Res. 68 2008 9574 9577
27. D.C. Radisky Epithelial-mesenchymal transition J. Cell Sci. 118 2005 4325 4326
28. H. Peinado, E. Ballestar, M. Esteller, and A. Cano Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex Mol. Cell. Biol. 24 2004 306 319
29. S. Biswas, M.R. Emond, and J.D. Jontes Protocadherin-19 and N-cadherin interact to control cell movements during anterior neurulation J. Cell Biol. 191 2010 1029 1041
30. M.R. Emond, S. Biswas, C.J. Blevins, and J.D. Jontes A complex of Protocadherin-19 and N-cadherin mediates a novel mechanism of cell adhesion J. Cell Biol. 195 2011 1115 1121